Why the study?
Does ECG gated P-31 MRS detect differences in myocardial high-energy phosphate metabolism between patients with cardiomyopathies and normal subjects?
Does ECG gated P-31 MRS detect differences in myocardial high-energy phosphate metabolism between patients with cardiomyopathies and normal subjects?
ECG gated P-31 MR spectroscopy can non-invasively identify myocardial metabolic disturbances in patients with hypertrophic cardiomyopathy and specific heart muscle disease.
No takes yet. Share an insight, caveat, or question.
May enable noninvasive metabolic phenotyping in HCM; leaves open whether P-31 MRS improves risk stratification.
Masuda et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: